Discover my current regimen (since August 2015) more info

Examining Rosacea In-Depth

Book Extract

This article is an extract from: Seborrheic Dermatitis - The Owner's Manual; a book dedicated to understanding seborrheic dermatitis. See the book overview page for more information.

  • Rosacea is a common skin condition often linked to genetics and environmental factors.
  • Symptoms include facial redness, bumps, eye irritation, and visible blood vessels.
  • While similar to seborrheic dermatitis, rosacea has distinct underlying causes and treatments.
  • Diagnosis is based on symptoms, as there are no definitive lab tests.
  • Management focuses on symptom control and trigger avoidance, with various treatments available.
Image for Understanding Rosacea In-Depth

Understanding Rosacea In-Depth

Rosacea is a chronic skin condition frequently observed alongside seborrheic dermatitis. While both share some symptoms, understanding their differences is key to effective management.

Genetics and family history appear to play a significant role in rosacea [], but environmental factors are equally important. Statistically, rosacea is more frequently diagnosed in women, yet it often presents more aggressively in men [1].

Like seborrheic dermatitis, rosacea tends to progress and spread if left unmanaged. Despite overlapping symptoms, their root causes and treatment strategies diverge significantly. Most practitioners focus on achieving initial symptom control followed by ongoing management rather than complete eradication.

Image for Recognizing Primary Rosacea Symptoms

Recognizing Primary Rosacea Symptoms

The hallmark symptoms of rosacea include [2, 3]:

  • Facial Redness (Erythema): Redness in areas similar to those affected by seborrheic dermatitis.
  • Swollen Red Bumps: Acne-like bumps on the skin.
  • Eye Issues: Dryness, irritation, and itching affecting the eyes.
  • Flushing: Sensations of heat and tingling on the skin.
  • Visible Blood Vessels (Telangiectasia): Small, noticeable blood vessels on the skin surface.
  • Red Nose: Characteristic redness of the nose.
  • Swelling (Edema): Fluid retention causing skin swelling.
  • Skin Dryness: Often a secondary symptom due to overlapping skin conditions or treatments.

A key differentiator from seborrheic dermatitis is the absence of primary skin flaking and abnormal sebum (oil) production in rosacea.

Topical Steroid Side Effects and Rosacea
It’s important to rule out topical steroid use as a cause of rosacea-like symptoms. Prolonged use of these medications can mimic rosacea [4, 5]. In such cases, symptoms are considered side effects and typically resolve after discontinuing steroid application.

Image for Rosacea and Seborrheic Dermatitis: Shared Aspects

Rosacea and Seborrheic Dermatitis: Shared Aspects

Although rosacea and seborrheic dermatitis differ in their origins, they share notable similarities.

Facial Area Involvement

Both conditions predominantly affect the face. This shared facial involvement can significantly impact self-esteem and social interactions, potentially leading to difficulties in work, relationships, and daily life.

Psychological Impact

Both rosacea and seborrheic dermatitis are recognized for their considerable psychological effects. The visible nature of these skin conditions can contribute to feelings of depression and social isolation in some individuals.

Stress and Skin: A Cyclical Connection
The link between stress and immune function suggests a cyclical relationship in these conditions. Psychological stress may exacerbate skin issues, which in turn can amplify stress levels, creating a feedback loop (stress -> skin issues -> increased stress).

Image for Rosacea: Core Concepts

Rosacea: Core Concepts

Despite extensive research, the medical community’s understanding of rosacea is still evolving. Global research on rosacea is growing, yet uncertainty persists regarding its complexities.

A significant portion of available literature may be influenced by funding from companies with vested interests in specific treatments, introducing potential biases [6]. This bias can lead to a wealth of proposed treatments without a corresponding increase in fundamental understanding of the condition itself.

Diagnosing Rosacea

Currently, no standardized lab tests exist to definitively diagnose rosacea [6]. Diagnosis primarily relies on a healthcare professional’s expertise in recognizing common rosacea symptoms and subtypes, and differentiating them from similar conditions.

Accurate diagnosis involves not just identifying rosacea, but also pinpointing the specific subtype. Subtype identification is crucial for tailoring effective treatment strategies [7].

For instance, individuals experiencing mainly facial flushing, skin sensitivity, and redness often react poorly to many topical treatments. Conversely, those with bumps/pimples (pustules/papules), increased oil production, and a butterfly-pattern redness tend to tolerate topical treatments better.

Four Rosacea Subtypes

Initially, rosacea was categorized into two main types: one characterized by redness and flushing, and another by papules and pustules. Currently, four distinct subtypes are recognized:

  1. Erythematotelangiectatic Rosacea: Characterized by skin flushing, persistent redness in specific areas, and potentially prominent blood vessels.
  2. Papulopustular Rosacea: Features the symptoms of the erythematotelangiectatic subtype, along with small bumps and papules.
  3. Phymatous Rosacea: Involves skin thickening and swelling, particularly affecting the nose (rhinophyma), chin, forehead, cheeks, and ears.
  4. Ocular Rosacea: Manifests as chronic eye irritation with symptoms like burning, stinging, dryness, itching, light sensitivity, and redness.

Image for Potential Rosacea Causes

Potential Rosacea Causes

The exact cause of rosacea remains unclear, and no single consensus has been reached. However, current research points to several contributing factors:

  • Vascular Abnormalities: Irregularities in facial blood flow are evident [8] and may be linked to hormonal imbalances, specifically vasoactive intestinal peptide [9], gastrin [10, 11], serotonin, and histamine [12]).
  • Altered Innate Immunity: The skin’s defense system uses antimicrobial peptides to combat infection and injury [13]. These peptides also mediate cellular communication and inflammation. Elevated levels of cathelicidins (an antimicrobial peptide) in rosacea-affected skin suggest an abnormal immune response [14, 15, 16].
  • Climactic Exposures: Prolonged skin exposure to environmental stressors like high heat or UV radiation can chronically damage facial blood vessels and connective tissues [8, 17, 18].
  • Dermal Matrix Degeneration: Issues within blood vessel linings [18, 19] and/or compromised connective tissues [20, 21] may lead to structural skin changes, increased vessel permeability, and localized pooling of blood, inflammatory agents, and metabolic waste.
  • Dietary and Chemical Triggers: Spicy foods, alcohol, and hot drinks are known rosacea flush triggers (not causes) [22, 23]. Certain medications, including topical/nasal steroids, nicotinic acid, and high-dose vitamin B6, can induce flushing or rosacea-like symptoms [5, 24, 25, 26, 27, 28].
  • Pilosebaceous Unit Abnormalities: Structural irregularities in the pilosebaceous unit [21, 29] (hair follicle, hair, arrector pili muscles, and sebaceous gland) may increase infiltration by inflammatory cells (neutrophils, eosinophils, lymphocytes, plasmacytes, macrophages, mast cells) and external antigens (Propionibacterium acnes and Demodex mites).
  • Demodex Mite Infestation: Overpopulation of Demodex mites in hair follicles (mites naturally present on skin) may contribute to rosacea progression [30, 31]. However, the exact role remains debated [21, 29], as improvement can occur without reducing mite counts [32, 33].
  • Helicobacter Pylori Infection: A possible link between rosacea and gastrointestinal issues [34] has raised suspicion that Helicobacter pylori infection could be a cause in some cases [35, 36, 37]. Studies on H. pylori eradication have yielded mixed results [38, 39, 40], and some suggest the overall effect of antibiotics, rather than specifically H. pylori elimination, may be responsible for improvements [41, 42].

The persistent uncertainty surrounding rosacea’s causes may stem from unidentified factors or individual variations among sufferers. Future research and technologies may provide clearer insights.

Image for Rosacea Treatment Strategies

Rosacea Treatment Strategies

Given rosacea’s complex nature, no single treatment guarantees complete symptom resolution. Much of the literature suggests rosacea is a chronic condition requiring ongoing management. However, this remains debated, and evolving knowledge may change this perspective.

Regardless of the long-term outlook, understanding common treatment approaches can offer valuable insights and potential relief.

Common rosacea treatments include:

  • Trigger avoidance (diet, environment, medications, etc.)
  • Systemic antibiotics (tetracycline or metronidazole)
  • Isotretinoin
  • Topical antibiotics (metronidazole, clindamycin phosphate, permethrin)
  • Topical retinoids and precursors (tretinoin or retinaldehyde)
  • Sulfur (with or without sodium sulfacetamide)
  • Azelaic acid

Many treatments are effective for specific symptoms (e.g., redness or pustules/papules), and combination therapies are frequently used.

Trigger Avoidance

Early in rosacea management, identifying and minimizing triggers can effectively reduce overall symptom severity, particularly skin redness [43, 44].

Common rosacea triggers include [44]:

  • Foods:
    • Liver and smoked meats
    • Yogurt, sour cream, hard cheeses (excluding cottage cheese)
    • Avocados, bananas, red plums, raisins, figs, citrus fruits
    • Eggplant, tomatoes, spinach, lima beans, navy beans, peas
    • Chocolate and vanilla
    • Soy sauce and vinegar
    • Hot and spicy foods
    • High-yeast foods
  • Beverages:
    • Alcoholic beverages, especially red wine
    • Hot drinks
  • Stress and Anxiety
  • Environmental Factors:
    • Sun exposure
    • Strong winds
    • Extreme humidity (high or low)
    • Temperature extremes (hot or cold)
  • Skincare Products:
    • Alcohol, witch hazel, fragrances, menthol, eucalyptus oil, clove oil, peppermint, sodium lauryl sulfate
    • Harsh cleansers (e.g., bar soap)
    • Over-washing
    • Aggressive exfoliation
  • Medications:
    • Vasodilators
    • Topical steroids
  • Medical Conditions:
    • Menopause
    • Caffeine withdrawal
    • Chronic cough
  • Excessive Physical Exertion

Identifying personal triggers often requires trial and error. It’s crucial to maintain a pragmatic approach and avoid impulsive treatment changes, as stress from constant switching can itself exacerbate rosacea.

Systemic Antibiotics

Metronidazole and tetracycline have long been used to treat rosacea [45, 46]. Doxycycline is currently the only FDA-approved tetracycline for rosacea [47, 48].

Long-term systemic antibiotic use is limited by potential complications [49, 50, 51, 52] (especially with tetracyclines) and relapse risk after treatment ends [53].

Oral antibiotics primarily target pustules and papules, with less impact on redness (erythema). Careful risk-benefit assessment with a healthcare professional is essential before starting systemic antibiotics.

Antibacterial vs. Anti-inflammatory Effects
The anti-inflammatory properties of antibiotics may be more significant for rosacea symptom reduction than their antibacterial actions [54, 48].

Isotretinoin

Isotretinoin, a synthetic retinoid related to retinol, is a common acne treatment that is also effective for rosacea [55, 56]. It notably improves papules and pustules [57] and reduces redness [58, 59].

However, isotretinoin intolerance and side effects are common, including mucosal dryness, lip inflammation (cheilitis), skin inflammation (dermatitis), muscle/joint pain, headaches, and elevated triglycerides [60, 61].

Topical Antibiotics

Topical antibiotics minimize systemic side effects by targeting application to affected areas. However, antibiotic resistance remains a potential concern [62, 63].

Metronidazole and tetracycline are frequently used topical options [64, 65] in creams, lotions, and gels. Clindamycin phosphate and permethrin are also used topically.

Topical Retinoids and Retinoid Precursors

Inspired by isotretinoin’s efficacy, topical approaches using retinoids have been explored.

Tretinoin, another retinoic acid for acne, shows promise for rosacea. Topical tretinoin was comparable to systemic isotretinoin in reducing both papules/pustules and redness [66]. However, adverse reactions are common [67, 68].

Retinaldehyde, a natural retinol precursor, requires skin conversion to retinoic acid or retinal [69]. Studies suggest retinaldehyde is better tolerated than tretinoin [70] and effectively reduces rosacea-related redness [71].

Sulfur

Sulfur is a more natural topical rosacea treatment. Some studies suggest it has similar efficacy to antibiotics in symptom reduction, potentially with fewer long-term side effects [72].

A common complaint is sulfur’s distinct odor, which can linger after washing.

Combining sulfur with sodium sulfacetamide (which also has anti-inflammatory and antibacterial properties [73]) may enhance effectiveness and reduce the required sulfur concentration [74]. However, some may prefer sulfur alone to minimize potential adverse reactions.

Azelaic Acid

Azelaic acid, another acne treatment, is also effective for rosacea. Some studies suggest it’s a viable alternative to topical metronidazole [75].

Benefits include its natural origin and reduced risk of long-term side effects [76].

Interestingly, azelaic acid is produced by Malassezia furfur, a yeast implicated in seborrheic dermatitis [77], yet topical azelaic acid improves seborrheic dermatitis symptoms [78].

Exploring Natural Rosacea Treatments

Due to inconsistent results and concerns about side effects with conventional treatments, interest in natural alternatives is growing.

Based on current research, two natural approaches show particular promise:

  • Niacinamide and Zinc Supplementation: A supplement containing 750mg nicotinamide, 25mg zinc, 1.5mg copper, and 500mcg folic acid daily showed rosacea improvements comparable to oral antibiotics [79]. This is attributed to anti-inflammatory, bacteriostatic, and sebum-reducing properties [80].
  • Licorice Extract: Licorice, known for its anti-inflammatory properties, has historical medicinal use. Topical ointments with specific licorice extracts have significantly reduced redness and inflammation in mild rosacea [81], atopic dermatitis [82], and UV-induced redness [83].

Other natural approaches with potential benefits based on their skin-healing and anti-inflammatory properties [84, 85, 86] include:

  • Green tea washes and extracts
  • Topical aloe vera
  • Topical chamomile
  • Turmeric supplements
  • Mushroom extracts
  • Probiotics
  • Omega-3 fatty acids

While anecdotal reports of effectiveness exist for these, specific research on their use in rosacea is still limited.

Image for Rosacea: Key Takeaways

Rosacea: Key Takeaways

This article provides a detailed overview of rosacea and its relationship to seborrheic dermatitis. While many questions remain unanswered, this information serves as a helpful starting point for those affected by rosacea.

  1. Rosacea is an inflammatory skin condition primarily affecting the face, often localized to specific areas, and with a likely genetic component.
  2. Rosacea frequently co-occurs with seborrheic dermatitis, but they are distinct conditions, primarily differing in sebum’s role.
  3. Rosacea is classified into four subtypes, and accurate subtyping is crucial for targeted treatment selection.
  4. Potential rosacea causes include blood flow irregularities, immune system dysfunction, UV damage, skin structure changes, Demodex mites, digestive issues, and dietary factors.
  5. Prolonged steroid use can mimic rosacea symptoms; steroid cessation usually leads to symptom improvement in these cases.
  6. Despite extensive research, a definitive single cause remains elusive, possibly due to individual variations among rosacea sufferers.
  7. Common treatments include trigger avoidance (diet, stress, medications), topical and systemic antibiotics, and immune-modulating agents.
  8. Natural treatment options like sulfur, azelaic acid, niacinamide/zinc supplements, and licorice extract ointments may be considered.

Book Extract

This article is an extract from: Seborrheic Dermatitis - The Owner's Manual; a book dedicated to understanding seborrheic dermatitis. See the book overview page for more information.

References

  1. H E Baldwin "Systemic therapy for rosacea." Skin therapy letter 12.2 (2007): 1-5, 9. PubMed
  2. Jonathan Wilkin, Mark Dahl, Michael Detmar, Lynn Drake, Matthew H Liang, Richard Odom, Frank Powell "Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea." Journal of the American Academy of Dermatology 50.6 (2004): 907-12. PubMed
  3. Carsten Sauer Mikkelsen, Helene Ringe Holmgren, Petra Kjellman, Michael Heidenheim, Ari Kappinnen, Peter Bjerring, Theis Huldt-Nystrøm "Rosacea: a Clinical Review." Dermatology reports 8.1 (2017): 6387. PubMed
  4. Yasmeen J Bhat, Sheikh Manzoor, Seema Qayoom "Steroid-induced rosacea: a clinical study of 200 patients." Indian journal of dermatology 56.1 (2011): 30-2. PubMed
  5. J J Leyden, M Thew, A M Kligman "Steroid rosacea." Archives of dermatology 110.4 (1974): 619-22. PubMed
  6. Glen H Crawford, Michelle T Pelle, William D James "Rosacea: I. Etiology, pathogenesis, and subtype classification." Journal of the American Academy of Dermatology 51.3 (2005): 327-41; quiz 342-4. PubMed
  7. S B Lonne-Rahm, T Fischer, M Berg "Stinging and rosacea." Acta dermato-venereologica 79.6 (2000): 460-1. PubMed
  8. J K Wilkin "Rosacea. Pathophysiology and treatment." Archives of dermatology 130.3 (1994): 359-62. PubMed
  9. U Wollina "Rhinophyma–unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells." Histology and histopathology 11.1 (1996): 111-5. PubMed
  10. M Y Chowers, N Keller, R Tal, I Barshack, R Lang, S Bar-Meir, Y Chowers "Human gastrin: a Helicobacter pylori–specific growth factor." Gastroenterology 117.5 (1999): 1113-8. PubMed
  11. A Rebora "Rosacea." The Journal of investigative dermatology 88.3 Suppl (1987): 56s-60s. PubMed
  12. M Guarrera, A Parodi, C Cipriani, C Divano, A Rebora "Flushing in rosacea: a possible mechanism." Archives of dermatological research 272.3-4 (1983): 311-6. PubMed
  13. Richard L Gallo "Sounding the alarm: multiple functions of host defense peptides." The Journal of investigative dermatology 128.1 (2008): 5-6. PubMed
  14. Kenshi Yamasaki, Richard L Gallo "Rosacea as a disease of cathelicidins and skin innate immunity." The journal of investigative dermatology. Symposium proceedings 15.1 (2012): 12-5. PubMed
  15. Kenshi Yamasaki, Anna Di Nardo, Antonella Bardan, Masamoto Murakami, Takaaki Ohtake, Alvin Coda, Robert A Dorschner, Chrystelle Bonnart, Pascal Descargues, Alain Hovnanian, Vera B Morhenn, Richard L Gallo "Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea." Nature medicine 13.8 (2007): 975-80. PubMed
  16. Suzanna Salzer, Thomas Ruzicka, Jürgen Schauber "Face-to-face with anti-inflammatory therapy for rosacea." Experimental dermatology 23.6 (2015): 379-81. PubMed
  17. Nicola Balato, Matteo Megna, Fabio Ayala, Anna Balato, Maddalena Napolitano, Cataldo Patruno "Effects of climate changes on skin diseases." Expert review of anti-infective therapy 12.2 (2014): 171-81. PubMed
  18. M A Mc Aleer, N Lacey, F C Powell "The pathophysiology of rosacea." Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 144.6 (2010): 663-71. PubMed
  19. E Neumann, A Frithz "Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea." International journal of dermatology 37.4 (1998): 263-6. PubMed
  20. T J Ryan "The blood vessels of the skin." The Journal of investigative dermatology 67.1 (1976): 110-8. PubMed
  21. R Marks, J N Harcourt-Webster "Histopathology of rosacea." Archives of dermatology 100.6 (1970): 683-91. PubMed
  22. J K Wilkin "Oral thermal-induced flushing in erythematotelangiectatic rosacea." The Journal of investigative dermatology 76.1 (1981): 15-8. PubMed
  23. R Marks "Concepts in the pathogenesis of rosacea." The British journal of dermatology 80.3 (1968): 170-7. PubMed
  24. H L Franco, W L Weston "Steroid rosacea in children." Pediatrics 64.1 (1979): 36-8. PubMed
  25. C A Egan, T M Rallis, K P Meadows, G G Krueger "Rosacea induced by beclomethasone dipropionate nasal spray." International journal of dermatology 38.2 (1999): 133-4. PubMed
  26. J K Wilkin "Why is flushing limited to a mostly facial cutaneous distribution?" Journal of the American Academy of Dermatology 19.2 Pt 1 (1988): 309-13. PubMed
  27. E F Sherertz "Acneiform eruption due to “megadose” vitamins B6 and B12." Cutis 48.2 (1991): 119-20. PubMed
  28. T Jansen, R Romiti, A Kreuter, P Altmeyer "Rosacea fulminans triggered by high-dose vitamins B6 and B12." Journal of the European Academy of Dermatology and Venereology : JEADV 15.5 (2002): 484-5. PubMed
  29. A A Ramelet, G Perroulaz "[Rosacea: histopathologic study of 75 cases]." Annales de dermatologie et de venereologie 115.8 (1989): 801-6. PubMed
  30. Yin-Shuo Chang, Yu-Chen Huang "Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis." Journal of the American Academy of Dermatology 77.3 (2017): 441-447.e6. PubMed
  31. A M Abd-El-Al, A M Bayoumy, E A Abou Salem "A study on Demodex folliculorum in rosacea." Journal of the Egyptian Society of Parasitology 27.1 (1997): 183-95. PubMed
  32. E Bonnar, P Eustace, F C Powell "The Demodex mite population in rosacea." Journal of the American Academy of Dermatology 28.3 (1993): 443-8. PubMed
  33. T W Robinson "Demodex folliculorum and rosacea. A clinical and histological study." Archives of dermatology 92.5 (1966): 542-4. PubMed
  34. R Marks, R J Beard, M L Clark, M Kwok, W B Robertson "Gastrointestinal observations in rosacea." Lancet (London, England) 1.7493 (1967): 739-43. PubMed
  35. S Zandi, S Shamsadini, M J Zahedi, M Hyatbaksh "Helicobacter pylori and rosacea." Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 9.1-2 (2004): 167-71. PubMed
  36. A Rebora, F Drago, A Parodi "May Helicobacter pylori be important for dermatologists?" Dermatology (Basel, Switzerland) 191.1 (1996): 6-8. PubMed
  37. L Ie Abrahamovych "[The clinico-morphofunctional status of the esophagogastroduodenal system in patients with acne rosacea: the etiological, pathogenetic and treatment aspects]." Likars'ka sprava.10-12 (1997): 84-8. PubMed
  38. H Herr, C H You "Relationship between Helicobacter pylori and rosacea: it may be a myth." Journal of Korean medical science 15.5 (2001): 551-4. PubMed
  39. K Kolibásová, I Tóthová, J Baumgartner, V Filo "Eradication of Helicobacter pylori as the only successful treatment in rosacea." Archives of dermatology 132.11 (1996): 1393. PubMed
  40. D Boixeda de Miquel, M Vázquez Romero, E Vázquez Sequeiros, J R Foruny Olcina, P Boixeda de Miquel, A López San Román, S Alemán Villanueva, C Martín de Argila de Prados "Effect of Helicobacter pylori eradication therapy in rosacea patients." Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 98.7 (2006): 501-9. PubMed
  41. M Candelli, E Carloni, E C Nista, I A Cazzato, G Pignataro, D Rigante, A Gasbarrini "Helicobacter pylori eradication and acne rosacea resolution: cause-effect or coincidence?" Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 36.2 (2004): 163. PubMed
  42. J T Bamford, R L Tilden, D E Gangeness "Does Helicobacter pylori eradication treatment reduce the severity of rosacea?" Journal of the American Academy of Dermatology 42.3 (2000): 535-6. PubMed
  43. M Giraud, M Croisille "[Diagnosis of adrenal gland tumors: retropneumoperitoneum and arteriography]." Annales de radiologie 11.11 (1969): 875-7. PubMed
  44. A K Gupta, M M Chaudhry "Rosacea and its management: an overview." Journal of the European Academy of Dermatology and Venereology : JEADV 19.3 (2005): 273-85. PubMed
  45. K J McClellan, S Noble "Topical metronidazole. A review of its use in rosacea." American journal of clinical dermatology 1.3 (2002): 191-9. PubMed
  46. Ali Alikhan, Laura Kurek, Steven R Feldman "The role of tetracyclines in rosacea." American journal of clinical dermatology 11.2 (2010): 79-87. PubMed
  47. James Q Del Rosso, Guy F Webster, Mark Jackson, Marta Rendon, Phoebe Rich, Helen Torok, Mark Bradshaw "Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea." Journal of the American Academy of Dermatology 56.5 (2007): 791-802. PubMed
  48. Brian Berman, Oliver A Perez, Deborah Zell "Update on rosacea and anti-inflammatory-dose doxycycline." Drugs of today (Barcelona, Spain : 1998) 43.1 (2007): 27-34. PubMed
  49. J Q Del Rosso "Systemic therapy for rosacea: focus on oral antibiotic therapy and safety." Cutis 66.4 Suppl (2001): 7-13. PubMed
  50. Wen-Qing Li, Eunyoung Cho, Hamed Khalili, Shaowei Wu, Andrew T Chan, Abrar A Qureshi "Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 14.2 (2016): 220-5.e1-3. PubMed
  51. R Gugler, J C Jensen, H Schulte, R Vogel "[The course of Crohn disease and side effect profile with long-term treatment using metronidazole]." Zeitschrift fur Gastroenterologie 27.11 (1990): 676-82. PubMed
  52. M Wienbren, R M Perinpanayagam, L Camba, C A Lee "Convulsions and encephalopathy in a patient with leukemia after treatment with metronidazole." Journal of clinical pathology 38.9 (1985): 1076. PubMed
  53. A G Knight, C F Vickers "A follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis." The British journal of dermatology 93.5 (1976): 577-80. PubMed
  54. Joseph B Bikowski "Subantimicrobial dose doxycycline for acne and rosacea." Skinmed 2.4 (2004): 234-45. PubMed
  55. Hyunhee Park, James Q Del Rosso "Use of oral isotretinoin in the management of rosacea." The Journal of clinical and aesthetic dermatology 4.9 (2012): 54-61. PubMed
  56. Meltem Uslu, Ekin Şavk, Göksun Karaman, Neslihan Şendur "Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements." Acta dermato-venereologica 92.1 (2012): 73-7. PubMed
  57. K Turjanmaa, T Reunala "Isotretinoin treatment of rosacea." Acta dermato-venereologica 67.1 (1987): 89-91. PubMed
  58. E Hoting, E Paul, G Plewig "Treatment of rosacea with isotretinoin." International journal of dermatology 25.10 (1987): 660-3. PubMed
  59. F G Erdogan, P Yurtsever, D Aksoy, F Eskioglu "Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea." Archives of dermatology 134.7 (1998): 884-5. PubMed
  60. A Charakida, P E Mouser, A C Chu "Safety and side effects of the acne drug, oral isotretinoin." Expert opinion on drug safety 3.2 (2004): 119-29. PubMed
  61. J McLane "Analysis of common side effects of isotretinoin." Journal of the American Academy of Dermatology 45.5 (2001): S188-94. PubMed
  62. Whitney P Bowe "Antibiotic resistance and acne: where we stand and what the future holds." Journal of drugs in dermatology : JDD 13.6 (2015): s66-70. PubMed
  63. Ted Rosen "Antibiotic resistance: an editorial review with recommendations." Journal of drugs in dermatology : JDD 10.7 (2011): 724-33. PubMed
  64. N K Veien, J V Christiansen, N Hjorth, H Schmidt "Topical metronidazole in the treatment of rosacea." Cutis 38.3 (1986): 209-10. PubMed
  65. M V Dahl, H I Katz, G G Krueger, L E Millikan, R B Odom, F Parker, J E Wolf, R Aly, C Bayles, B Reusser, M Weidner, E Coleman, R Patrignelli, M R Tuley, M O Baker, J H Herndon, J M Czernielewski "Topical metronidazole maintains remissions of rosacea." Archives of dermatology 134.6 (1998): 679-83. PubMed
  66. G A Ertl, N Levine, A M Kligman "A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea." Archives of dermatology 130.3 (1994): 319-24. PubMed
  67. Siddharth Mukherjee, Abhijit Date, Vandana Patravale, Hans Christian Korting, Alexander Roeder, Günther Weindl "Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety." Clinical interventions in aging 1.4 (2008): 327-48. PubMed
  68. E A Olsen, H I Katz, N Levine, J Shupack, M M Billys, S Prawer, J Gold, M Stiller, L Lufrano, E G Thorne "Tretinoin emollient cream: a new therapy for photodamaged skin." Journal of the American Academy of Dermatology 26.2 Pt 1 (1992): 215-24. PubMed
  69. G Siegenthaler, J H Saurat, M Ponec "Retinol and retinal metabolism. Relationship to the state of differentiation of cultured human keratinocytes." The Biochemical journal 268.2 (1990): 371-8. PubMed
  70. J H Saurat, L Didierjean, E Masgrau, P A Piletta, S Jaconi, D Chatellard-Gruaz, D Gumowski, I Masouyé, D Salomon, G Siegenthaler "Topical retinaldehyde on human skin: biologic effects and tolerance." The Journal of investigative dermatology 103.6 (1995): 770-4. PubMed
  71. M P Vienne, N Ochando, M T Borrel, Y Gall, C Lauze, P Dupuy "Retinaldehyde alleviates rosacea." Dermatology (Basel, Switzerland) 199 Suppl 1 (1999): 53-6. PubMed
  72. I Blom, A M Hornmark "Topical treatment with sulfur 10 per cent for rosacea." Acta dermato-venereologica 64.4 (1985): 358-9. PubMed
  73. Kristin Wolf, Sirunya Silapunt "The use of sodium sulfacetamide in dermatology." Cutis 96.2 (2016): 128-30. PubMed
  74. Helen M Torok, Guy Webster, Frank E Dunlap, Nancy Egan, Michael Jarratt, Daniel Stewart "Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea." Cutis 75.6 (2005): 357-63. PubMed
  75. Janusz Czernielewski, Yin Liu "Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea." Archives of dermatology 140.10 (2004): 1282-3; author reply 1283. PubMed
  76. Diane Thiboutot, Ruth Thieroff-Ekerdt, Klaus Graupe "Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies." Journal of the American Academy of Dermatology 48.6 (2003): 836-45. PubMed
  77. M Nazzaro-Porro, S Passi "Identification of tyrosinase inhibitors in cultures of Pityrosporum." The Journal of investigative dermatology 71.3 (1978): 205-8. PubMed
  78. Joseph Bikowski "Facial seborrheic dermatitis: a report on current status and therapeutic horizons." Journal of drugs in dermatology : JDD 8.2 (2009): 125-33. PubMed
  79. Neil M Niren, Helen M Torok "The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial." Cutis 77.1 Suppl (2006): 17-28. PubMed
  80. David P Fivenson "The mechanisms of action of nicotinamide and zinc in inflammatory skin disease." Cutis 77.1 Suppl (2006): 5-10. PubMed
  81. T M Weber, R I Ceilley, A Buerger, L Kolbe, N S Trookman, R L Rizer, A Schoelermann "Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A." Journal of cosmetic dermatology 5.3 (2008): 227-32. PubMed
  82. M Saeedi, K Morteza-Semnani, M-R Ghoreishi "The treatment of atopic dermatitis with licorice gel." The Journal of dermatological treatment 14.3 (2003): 153-7. PubMed
  83. Ludger Kolbe, Jeannine Immeyer, Jan Batzer, Ursula Wensorra, Karen tom Dieck, Claudia Mundt, Rainer Wolber, Franz Stäb, Uwe Schönrock, Roger I Ceilley, Horst Wenck "Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects." Archives of dermatological research 298.1 (2007): 23-30. PubMed
  84. Jason Emer, Heidi Waldorf, Diane Berson "Botanicals and anti-inflammatories: natural ingredients for rosacea." Seminars in cutaneous medicine and surgery 30.3 (2012): 148-55. PubMed
  85. Mary-Margaret Kober, Whitney P Bowe "The effect of probiotics on immune regulation, acne, and photoaging." International journal of women's dermatology 1.2 (2017): 85-89. PubMed
  86. Rahul Bhargava, Mini Chandra, Utsav Bansal, Divya Singh, Somesh Ranjan, Shalini Sharma "A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms." Current eye research 41.10 (2017): 1274-1280. PubMed
Last Updated:
in Rosacea   0

About Michael Anders

After being affected by seborrheic dermatitis, I have made it my goal to gather and organize all the information that has helped me in my journey.

Share Your Thoughts

(will not be published)

No Comments

Be the first to start a conversation